Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in NASHSino...